Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 523-526, 2006; 10.1373/clinchem.2005.058883
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atamaniuk, J.
Right arrow Articles by Mueller, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atamaniuk, J.
Right arrow Articles by Mueller, M. M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2006;52:523-526.)
© 2006 American Association for Clinical Chemistry, Inc.


Technical Briefs

Cell-Free Plasma DNA: A Marker for Apoptosis during Hemodialysis

Johanna Atamaniuk1,a, Katharina Ruzicka1, Karl M. Stuhlmeier2, Alireza Karimi1, Manfred Eigner3 and Mathias M. Mueller1

1 Institute of Laboratory Diagnostics, and3 First Medical Department, Dialysis Unit, Kaiser Franz Josef Hospital, Vienna, Austria;2 Ludwig Boltzmann Institute for Rheumatology, Vienna, Austria;

aaddress correspondence to this author at: Institute of Laboratory Diagnostics, Kaiser Franz Josef Hospital, Kundratstrasse 3, A-1100, Vienna, Austria; fax 43-60191-3309, e-mail johanna.atamaniuk{at}wienkav.at


Abstract

Background: We evaluated whether cell-free plasma DNA might be an appropriate marker for cell damage during hemodialysis (HD) and whether it correlated with annexin V expression and 7-amino-actinomycin D (7AAD) nuclear staining of blood leukocytes.

Methods: Circulating DNA, annexin V, and 7AAD were measured in HD patients before HD, 20 min after start of HD, and after HD had ended. Healthy volunteers provided control measurements. Necrosis and apoptosis were monitored by gel electrophoresis.

Results: Plasma DNA concentrations were not significantly different between controls and patients before HD. Circulating DNA increased significantly (P <0.05) after 20 min of treatment with HD. Post-HD concentrations of DNA were significantly higher compared with pre-HD and controls (P <0.005). Agarose gel electrophoresis showed ladders typical of apoptosis in post-HD samples. Two subpopulations of CD45+ leukocytes were defined by flow cytometry: annexin V+/7AAD+ population for apoptosis, and annexin V+/7AAD– for early apoptosis. Compared with healthy controls, mean fluorescence (MF) of 7AAD+ apoptotic cells in the annexin V+/7AAD+ subpopulation before HD was not significantly increased. HD increased MF of 7AAD+ cells in the annexin V+/7AAD+ subpopulation. In this subpopulation, MF of annexin V+ cells was significantly higher (P <0.01). MF of annexin V+ cells in the annexin V+/7AAD+ subpopulation increased during HD.

Conclusions: During HD, cell-free plasma DNA concentrations, annexin V expression, and 7AAD uptake in leukocytes increases. The increase in plasma DNA, appearing as ladders typical of apoptosis, and the 7AAD uptake in leukocytes demonstrate that the predominant portion of circulating DNA in HD patients originates from apoptotic leukocytes.

Membranes used in hemodialysis (HD) are made of cellulose (e.g., cuprophan), modified cellulose (e.g., cellulose acetate), or synthetic polymers (e.g., polysulfone). Studies based on a large number of patients have shown that the mortality rate of individuals undergoing HD with unsubstituted cellulose membranes was higher than with synthetic or modified cellulose membranes (1). During HD, blood-membrane interactions lead to activation of circulating cells, plasma proteins, (2), and the complement system (3). Furthermore, contact of cells with less biocompatible membranes in vitro can lead to apoptosis (4). Exposure of normal neutrophils to uremic plasma accelerates in vitro apoptosis compared with cells incubated with normal plasma (2). The apoptosis-inducing activity of uremic plasma is modulated by use of dialyzers with different degrees of biocompatibility (2). Dialysis membranes can promote neutrophil apoptosis directly as well as through their interactions with monocytes (5). Stimulation of mononuclear cells is likely caused by the interaction of cell-surface proteins with the dialysis membrane (6).

For detecting early and late apoptosis in leukocytes, complex methods are required, such as flow cytometric measurements of annexin V expression in combination with 7-amino-actinomycin D (7AAD) nuclei staining (6). In early apoptosis, phosphatidylserine (PS) is translocated from the inner to the outer surface of the plasma membrane. In the presence of Ca2+, annexin V has a high affinity for PS and binds only to PS that has been exposed (7). Cells in the late stages of apoptosis and dead cells have lost plasma membrane integrity and are permeable for 7AAD (8). Increased apoptosis in leukocytes after HD was reported when they were cultured for 12 to 48 h (2)(6)(9).

Cell-free DNA concentrations are sensitive indicators of cellular damage originating from apoptosis or necrosis (10)(11)(12). The aim of this study, therefore, was to evaluate whether circulating DNA may be an appropriate marker to demonstrate apoptosis during HD and whether it correlates with annexin V expression and 7AAD nuclear staining of blood leukocytes.

Blood samples were drawn from a control group of 30 healthy donors (10 men and 20 women; age range, 25–75 years) and from 10 HD patients (5 men; age range, 61–74 years; 5 women; age range, 46–80 years) before HD, 20 min after the start of HD, and after the end of HD. All patients had been treated in the dialysis program for more than 2 weeks; the longest period of dialysis treatment was 42 months. In the HD group, 8 patients were treated 3 times and 2 patients 2 times per week. The length of time per HD procedure was 3.5–4.5 h. Informed consent was obtained from all patients.

For HD, the same synthetic polymer membranes [Fresenius Polysulfone Capillary dialyzers (F6) low-flux] were used, and all patients were dialyzed through graft arteriovenous fistulas. The dialysate fluids and the water purity were routinely tested for bacteriologic contaminations and heavy metals. We administered the following medications to patients: parenteral iron [100 mg iron(III)-saccharose]; oral vitamins B1, B2, B6, and C, folic acid, biotin, and nicotinamide; and subcutaneous erythropoietin (1000–15000 IU). Exclusion criteria for our study were status post-kidney transplantation, autoimmune disease, malignancy, or acute infection.

We isolated DNA from 800 µL of plasma and measured it as published previously (10). After isolation and measurement of plasma DNA, agarose gel electrophoresis was performed. Agarose, at a final concentration of 1.5% dissolved in Tris-borate-EDTA buffer (pH 8.0), was used for electrophoresis, and after electrophoresis, gels were stained with Vistra Green (Amersham Pharmacia Biotech). In cases where higher sensitivity was needed, polyacrylamide gel electrophoresis was performed. Isolated plasma DNA samples were collected from 20 healthy volunteers and used after concentration (Microcon YM-100). The samples were separated on a 6% polyacrylamide gel [30% acrylamide/bis (Bio-Rad/Laboratories); 5x buffer (50 mmol/L Tris, 380 mmol/L glycerin, 2 mmol/L EDTA); 100 µg/mL ammonium persulfate; 0.85 µL/mL N,N,N',N'-tetramethylethylenediamine]. All chemicals were purchased from Sigma (Germany). Both gels were scanned on a FluorImager 595 (Amersham Biosciences).

To 0.5 mL of EDTA blood (4 °C), we added lysis buffer (8.99 g of ammonium chloride, 1.00 g of potassium hydrogen carbonate, 0.037 g of titriplex-III, and 100.0 mL of doubly distilled water) diluted 1:10 with doubly distilled water. After incubation (5 min at room temperature in the dark) and centrifugation (300g for 5 min at 4 °C) to pellet the leukocytes, the cells were washed at 4 °C with phosphate-buffered saline (Dulbecco’s W/O sodium bicarbonate buffer; Gibco) supplemented with 10 mL/L fetal calf serum (PromoCell®), and then washed with ice-cold calcium buffer (10 mmol/L HEPES/NaOH, pH 7.4; 140 mmol/L NaCl; 2.5 mmol/L CaCl2; IQ-Products) and adjusted to 1.5 x 103 cells/L.

We incubated 100 µL of cell suspension for 20 min in the dark at 4 °C with 10 µL of combined antibodies. Antibodies conjugated commercially to fluorescein isothiocyanate (FITC), phycoerythrin, peridinin-chlorophyll-protein (PerCP), and allophycocyanin (APC) dyes were used. The following tubes were provided: isotype control; anti-annexin V/FITC (IQ Products), 7AAD/PerCP (BD Pharmingen), and CD45/APC (Becton Dickinson); and anti-annexin V/FITC, CD45/phycoerythrin, 7AAD/PerCP, and CD14/APC. After incubation, the cells were washed and resuspended in ice-cold calcium buffer.

Surface marker analysis was performed by fluorescence-activated cell sorting with an FACSCalibur (Becton Dickinson). We acquired 10 000 events using CellQuest software (Becton Dickinson). We classified leukocytes as "normal" (annexin V– and 7AAD–), "early apoptotic" (annexin V+ and 7AAD–), and "apoptotic" (annexin V+ and 7AAD+).

Data were analyzed with STATISTICA for Windows, Ver. 6.0. Descriptive data are reported as the mean, median, and SD. Statistical significance was determined by Wilcoxon matched-pairs test for nonparametric variables. Statistical significance was defined as P <0.05.

Before HD, plasma DNA concentrations in patients were slightly increased [mean (SD), 13.89 (5.22) pg/µL] compared with controls [12.53 (4.70) pg/µL]. After 20 min of HD, plasma DNA concentrations [20.45 (10.27) pg/µL] were significantly increased (P <0.05) compared with pre-HD samples. During HD, plasma DNA continued to increase, with the highest concentrations at the end of HD [129.44 (83.38) pg/µL; P <0.005].

Agarose gel electrophoresis of plasma DNA obtained from samples after HD revealed the typical apoptotic ladders. In pre-HD samples and in samples taken after 20 min of HD, we could detect only attenuated ladders (Fig. 1A ).


Figure 1
View larger version (43K):
[in this window]
[in a new window]
 
Figure 1. Agarose gel separation of plasma DNA samples during HD (A), and polyacrylamide gel separation of concentrated cell-free plasma DNA samples (B).

(A), lane 1, molecular size ladder (100–1000 bp); lane 2, apoptosis control; lanes 3 and 4, plasma DNA samples immediately before dialysis and after 20 min of HD, respectively, showing only slightly increased ladders. Lane 5, for apoptosis, typically ladders appear in the DNA samples at the end of HD. (B), lane 1, molecular size ladder (100–1000 bp); lane 2, plasma DNA samples from 20 healthy volunteers concentrated into 1 sample. The pattern in lane 2 is typical of apoptotic ladders.

To demonstrate whether the cell-free DNA of healthy individuals originates from apoptosis or necrosis, we performed polyacrylamide gel electrophoresis, using concentrated DNA extracts from 20 healthy individuals. These experiments again demonstrated typical apoptosis ladders (Fig. 1BUp ). Thus, the predominant part of circulating DNA in healthy individuals originates from apoptosis.

To detect the mean fluorescence (MF) of annexin V and 7AAD, we monitored 2 distinct subpopulations of leukocytes: the annexin V+/7AAD+ (apoptotic), and annexin V+/7AAD– (early apoptotic) populations (Table 1 ).


View this table:
[in this window]
[in a new window]
 
Table 1. Flow cytometry results for CD45+ apoptotic leukocytes.

The MF of 7AAD in the apoptotic cell population showed no significant differences between the controls and HD patients before start of HD. During HD, the MF of the 7AAD+ cells increased from 710.1 to 998.9 in patients’ samples. In addition, the MF of annexin V+ cells from patients before HD was significantly higher (P <0.01) than in controls. During dialysis, we again detected significant changes in the MF of annexin V+ cells (P <0.05) in patients. The early apoptotic cell subpopulations in controls and dialysis patients showed annexin V+ MF of 578.2 (131.5) and 662.2 (73.0), respectively (P >0.05).

Uremia is associated with a state of immune dysfunction and increasing infection. Possibly, apoptosis relates to dysregulation of the immune system (13)(14). Cell-free plasma DNA has been found in many cases in which apoptosis or necrosis was involved, suggesting that such events are the main source for its presence. Measurement of circulating DNA has been used as a prognostic tool in the posttreatment monitoring of transplant patients (12). In addition, it has been shown that within 15 min to 3 h after major bodily injury, circulating DNA concentrations in the peripheral blood of trauma patients developing posttraumatic organ failure are significantly increased (15). In our previous study, we showed increased concentrations of plasma DNA immediately after exhaustive exercise and its disappearance within 2 h after the participants had stopped running (10). The rapid appearance and disappearance of circulating DNA seems to be a characteristic phenomenon for the nature of this DNA.

Using DNA separated on a polyacrylamide gel, we have demonstrated that circulating DNA in healthy volunteers shows ladders typical for apoptosis. Circulating DNA seems to be mainly a result of apoptosis. In support of our hypothesis, Fournie at al. (16) concluded in a previous study that degradation of leukocytes in the artificial kidney was responsible for the increase in circulation of extracellular DNA.

Our data for 7AAD and annexin V in CD45+ leukocytes, measured immediately after blood draw, demonstrate apoptotis of leukocytes in HD. Previous in vitro studies (9) have demonstrated increased apoptosis of leukocytes after cultivation mimicking uremic conditions. In our study, increases in the MF of 7AAD in cell populations and in circulating DNA during HD mainly reflect apoptosis induced by contact with the dialysis membrane.

The source of increased DNA concentrations seems to be apoptotic leukocytes. Possibly, DNA fragments are leaking from the nuclei of leukocytes. In our study, the increase in uptake of 7AAD in leukocytes indicates increased permeability. The rapid increase in circulating DNA during HD and the increase in 7AAD in leukocytes suggest that both are caused by apoptosis.


Acknowledgments

We thank Grandits Ernestine for excellent technical assistance.


References

  1. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50:566-570.[ISI][Medline] [Order article via Infotrieve]
  2. Jaber BL, Balakrishnan VS, Cendoroglo MN, Perianayagam MC, King AJ, Pereira BJ. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis. Blood Purif 1998;16:325-335.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Germin Petrovic D. Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis. Acta Med Croatica 2004;58:31-36.[Medline] [Order article via Infotrieve]
  4. Carracedo J, Ramirez R, Pintado O, Gomez-Villamandos JC, Martin-Malo A, Rodriguez M, et al. Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 1995;6:1586-1591.[Abstract]
  5. Nahar N, Shah H, Siu J, Colvin R, Bhaskaran M, Ranjan R, et al. Dialysis membrane-induced neutrophil apoptosis is mediated through free radicals. Clin Nephrol 2001;56:52-59.[ISI][Medline] [Order article via Infotrieve]
  6. Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, et al. Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 2000;11:936-942.[Abstract/Free Full Text]
  7. Peng ZH, Xing TH, Qiu GQ, Tang HM. Relationship between fas/fasl expression and apoptosis of colon adenocarcinoma cell lines. World J Gastroenterol 2001;7:88-92.[ISI][Medline] [Order article via Infotrieve]
  8. Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell discrimination with 7-amino-actinomycin d in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992;13:204-208.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  9. Majewska E, Baj Z, Sulowska Z, Rysz J, Luciak M. Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dial Transplant 2003;18:2582-2588.[Abstract/Free Full Text]
  10. Atamaniuk J, Vidotto C, Tschan H, Bachl N, Stuhlmeier KM, Muller MM. Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin Chem 2004;50:1668-1670.[Free Full Text]
  11. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001;313:139-142.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  12. Lui YY, Dennis YM. Circulating DNA in plasma and serum: biology, preanalytical issues, and diagnostic applications. Clin Chem Lab Med 2002;40:962-968.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  13. D’Intini V, Bordoni V, Fortunato A, Galloni E, Carta M, Galli F, et al. Longitudinal study of apoptosis in chronic uremic patients. Semin Dial 2003;16:467-473.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  14. Andrikos E, Buoncristiani E, D’Intini V, Bordoni V, Bonello M, Levin N, et al. Effect of daily hemodialysis on monocytes apoptosis. Blood Purif 2005;23:79-82.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  15. Rainer TH, Chan LY, Lit LC, Cocks RA. Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann N Y Acad Sci 2001;945:211-220.[ISI][Medline] [Order article via Infotrieve]
  16. Fournie GJ, Lule J, Dueymes JM, Laval F, Delobbe I, Vernier I, et al. Plasma DNA in patients undergoing hemodialysis or hemofiltration: cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol 1989;9:384-391.[ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Exp. Biol. Med.Home page
M. P. Langford, T. B. Redens, N. R. Harris, S. Lee, S. K. Jain, S. Reddy, and R. McVie
Plasma Levels of Cell-Free Apoptotic DNA Ladders and Gamma-Glutamyltranspeptidase (GGT) in Diabetic Children
Experimental Biology and Medicine, October 1, 2007; 232(9): 1160 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. E. Westerweel, I. E. Hoefer, P. J. Blankestijn, P. de Bree, D. Groeneveld, O. van Oostrom, B. Braam, H. A. Koomans, and M. C. Verhaar
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1132 - F1140.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. G. Fatouros, A. Destouni, K. Margonis, A. Z. Jamurtas, C. Vrettou, D. Kouretas, G. Mastorakos, A. Mitrakou, K. Taxildaris, E. Kanavakis, et al.
Cell-Free Plasma DNA as a Novel Marker of Aseptic Inflammation Severity Related to Exercise Overtraining
Clin. Chem., September 1, 2006; 52(9): 1820 - 1824.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atamaniuk, J.
Right arrow Articles by Mueller, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atamaniuk, J.
Right arrow Articles by Mueller, M. M.
Related Collections
Right arrow Molecular Diagnostics and Genetics


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS